DOSING REGIMEN

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15590042

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides for a dosing regimen for human antibodies that bind to human platelet-derived growth factor receptor alpha (PDGFR alpha), preferably olaratumab.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMCLONE LLCNEW YORK NY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BALDWIN, John Robert Martinsville, US 2 0
CONTI, Ilaria Carmel, US 2 0
CRONIER, Damien Michel Twickenham, GB 3 1
ILARIA,, Jr Robert Leslie Zionsville, US 3 1
MO, Zhi Lin Carmel, US 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation